Test cream made from cassia alata for skin rash
Part of Infections, Skin clinical trials.
This Phase 1 study tests how safe and how well a 20% cassia alata (a plant extract) cream works for tinea versicolor, a common skin condition. You may be able to join if your rash matches the study’s confirmed diagnosis and you have not used treatment recently.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be between 18 and 89 years old
- Have a skin rash that fits tinea versicolor, confirmed by skin scraping and stain test and/or a Wood’s lamp light exam
- Have not used any treatment for tinea versicolor in the last 4 weeks
- No known allergy to cassia alata (the plant extract)
- No known allergy to preservatives in creams/skin products
- Not be pregnant
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two common treatments for pityriasis versicolor, a fungal skin condition that causes light or dark patches: a cream applied to the skin versus an oral tablet. The goal is to see which works better in clearing the patches.
This study compares two medicated creams to treat pityriasis versicolor, a common fungal skin condition that causes discolored patches. You may be eligible if you have this condition and are generally healthy.
This study compares using a 2% ketoconazole shampoo for seven days versus three days to treat pityriasis versicolor, a common fungal skin condition that causes lighter or darker patches. The goal is to see which treatment duration works better at clearing the fungus.
This study compares two common antifungal pills, fluconazole and itraconazole, to see which works better for treating pityriasis versicolor, a skin condition that causes discolored patches. If you have this condition and are generally healthy, you may be able to join.
This study tests a cream called ruxolitinib for children with nonsegmental vitiligo. It aims to see if the cream can safely help restore skin color in affected areas.
This trial tests an ointment called MH004 to see if it helps repigment white patches in people with non-segmental vitiligo (the most common type). It focuses on patches on the face and body.
Hear when a new Pityriasis Versicolor trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.